MK-4256

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2016
0120122016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
MK-4256, a tetrahydro-β-carboline sstr3 antagonist, was discontinued due to a cardiovascular (CV) adverse effect observed in dogs… (More)
Is this relevant?
2015
2015
We report SAR studies on a novel non-peptidic somatostatin receptor 3 (SSTR3) agonist lead series derived from (4-phenyl-1H… (More)
Is this relevant?
2014
2014
Antagonism of somatostatin subtype receptor 3 (sstr3) has emerged as a potential treatment of Type 2 diabetes. Unfortunately, the… (More)
Is this relevant?
2012
2012
A structure-activity relationship study of the imidazolyl-β-tetrahydrocarboline series identified MK-4256 as a potent, selective… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?